These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 3890759

  • 1. [Inhibition of metastasis by anti-platelet agents-prostaglandins].
    Niitsu Y, Urushizaki I.
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1228-34. PubMed ID: 3890759
    [Abstract] [Full Text] [Related]

  • 2. [Cancer blood-borne metastasis and platelets].
    Tanaka K, Fukumoto S.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2453-9. PubMed ID: 6391385
    [Abstract] [Full Text] [Related]

  • 3. [Role of blood platelets and prostaglandins in blood-borne metastases].
    Tanaka K, Fukumoto S.
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1944-7. PubMed ID: 6614932
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation.
    Menter DG, Onoda JM, Moilanen D, Sloane BF, Taylor JD, Honn KV.
    J Natl Cancer Inst; 1987 May; 78(5):961-9. PubMed ID: 3553692
    [Abstract] [Full Text] [Related]

  • 5. Possible strategies for antimetastastic therapy.
    Honn KV, Onoda JM, Menter DG, Cavanaugh PG, Taylor JD, Crissman JD, Ryan RE, Sloane BF.
    Prog Clin Biol Res; 1986 May; 212():217-49. PubMed ID: 3520578
    [No Abstract] [Full Text] [Related]

  • 6. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Ambrus JL, Ambrus CM, Gastpar H.
    Prog Clin Biol Res; 1982 May; 89():83-95. PubMed ID: 7111311
    [No Abstract] [Full Text] [Related]

  • 7. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL, Ambrus CM, Gastpar H, Williams P.
    J Med; 1982 May; 13(1-2):35-47. PubMed ID: 6288824
    [Abstract] [Full Text] [Related]

  • 8. Platelet cancer cell interaction in metastasis formation. Platelet aggregation inhibitors: a possible approach to metastasis prevention.
    Gastpar H, Ambrus JL, Ambrus CM.
    Prog Clin Biol Res; 1982 May; 89():63-82. PubMed ID: 7111310
    [Abstract] [Full Text] [Related]

  • 9. Effects of prostacyclin on tumor cell-induced platelet aggregation.
    Menter DG, Onoda JM, Taylor JD, Honn KV.
    Cancer Res; 1984 Feb; 44(2):450-6. PubMed ID: 6362850
    [Abstract] [Full Text] [Related]

  • 10. Interaction of platelets and tumor cells.
    Steiner M.
    Prog Clin Biol Res; 1982 Feb; 89():383-403. PubMed ID: 7111305
    [No Abstract] [Full Text] [Related]

  • 11. Potential role of platelets and coagulation factors in the metastasis of prostatic cancer.
    Bhatti RA, Gadarowski J, Ray P.
    Invasion Metastasis; 1996 Feb; 16(2):49-55. PubMed ID: 9030239
    [Abstract] [Full Text] [Related]

  • 12. Role of prostacyclin as a natural deterrent to hematogenous tumor metastasis.
    Honn KV, Menter DG, Onoda JM, Taylor JD, Sloane BF.
    Symp Fundam Cancer Res; 1983 Feb; 36():361-88. PubMed ID: 6382514
    [No Abstract] [Full Text] [Related]

  • 13. Platelet-aggregating activities of metastasizing tumor cells. II. Variety of the aggregation mechanisms.
    Tohgo A, Tanaka N, Ashida S, Ogawa H.
    Invasion Metastasis; 1984 Feb; 4(3):134-45. PubMed ID: 6480287
    [Abstract] [Full Text] [Related]

  • 14. [Tumor-induced platelet aggregation and growth-promoting factors as determinants of probable tumor metastasis].
    Tsuruo T.
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2033-9. PubMed ID: 3606138
    [Abstract] [Full Text] [Related]

  • 15. [Differentiation induction and potentiation of chemotherapy by PGE1 infusion in patients with neuroblastoma--effect of PGE1 on metastatic potential of neuroblastoma].
    Imashuku S, Esumi N, Todo S, Nakajima F.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):775-80. PubMed ID: 6585182
    [Abstract] [Full Text] [Related]

  • 16. The use of a perfusion model for studying aggregation and attachment of platelets and tumor cells at subendothelial surfaces.
    Ordinas A, Marcum JM, McGill M, Bastida E, Jamieson GA.
    Prog Clin Biol Res; 1982 Mar; 89():373-82. PubMed ID: 7111304
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL, Harker LA, Andersen NH, Wilson CH.
    Adv Prostaglandin Thromboxane Res; 1980 Mar; 6():389-93. PubMed ID: 6247888
    [No Abstract] [Full Text] [Related]

  • 18. Study of platelet aggregation in vivo: II. Effect of bencyclan on circulating metastatic tumor cells.
    Gastpar H, Ambrus J, Thurber LE.
    J Med; 1977 Mar; 8(1):53-6. PubMed ID: 267156
    [Abstract] [Full Text] [Related]

  • 19. [Disordered function of the vascular-thrombocyte link in the hemostatic system during tumor growth].
    Liubina LV, Tlepshukov IK.
    Biull Eksp Biol Med; 1989 Dec; 108(12):716-8. PubMed ID: 2634448
    [Abstract] [Full Text] [Related]

  • 20. Animal models for the study of platelet-tumor cell interactions.
    Donati MB, Rotillio D, Delaini F, Giavazzi R, Mantovani A, Poggi A.
    Prog Clin Biol Res; 1982 Dec; 89():159-76. PubMed ID: 7202205
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.